Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $15.0800 (0%) ($14.3500 - $15.3400) on Fri. Jan. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.29% (three month average) | RSI | 54 | Latest Price | $15.0800(0%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IFRA(28%) QQQ(28%) XLC(27%) SKYY(26%) IBB(25%) | Factors Impacting SONN price | SONN will decline at least -2.145% in a week (0% probabilities). VCSH(-35%) TLT(-29%) LQD(-27%) CEMB(-26%) BNDX(-23%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.145% (StdDev 4.29%) | Hourly BBV | 0 () | Intraday Trend | 5.1% | | | |
|
5 Day Moving Average | $15.14(-0.4%) | 10 Day Moving Average | $15.01(0.47%) | 20 Day Moving Average | $14.96(0.8%) | To recent high | -34.1% | To recent low | 6.8% | Market Cap | $139m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |